Patents by Inventor Sara L. Zaknoen

Sara L. Zaknoen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130084281
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: June 21, 2012
    Publication date: April 4, 2013
    Applicant: Tragara Pharmaceuticals, Inc.
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
  • Patent number: 8247423
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: August 21, 2012
    Assignee: Tragara Pharmaceuticals, Inc.
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
  • Publication number: 20120052061
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: September 23, 2008
    Publication date: March 1, 2012
    Applicant: Tragara Pharmaceuticals Inc.
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
  • Publication number: 20120015919
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: September 23, 2008
    Publication date: January 19, 2012
    Applicant: Tragara Pharmaceuticals, Inc.
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
  • Publication number: 20120016002
    Abstract: Disclosed herein are methods related generally to a patient selection process for identifying individuals for treatment of cancer, inflammation, pain, and/or related conditions.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 19, 2012
    Applicant: TRAGARA PHARMACEUTICALS ,Inc.
    Inventors: Tracy Lawhon, Sara L. Zaknoen, Thomas Estok, Mark Green
  • Publication number: 20110306572
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: September 23, 2008
    Publication date: December 15, 2011
    Applicant: TRAGARA PHARMACEUTICALS, INC
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield
  • Publication number: 20110301169
    Abstract: A method for treating a subject having cancer, comprising administering to the subject, a therapeutically effective amount of a combination comprising a 1,2-diphenylpyrrole derivative or the respective pharmaceutically acceptable salt, solvate, polymorph or prodrug and an anti-metabolite.
    Type: Application
    Filed: November 24, 2008
    Publication date: December 8, 2011
    Inventors: Sara L. Zaknoen, Tracy Lawhon
  • Publication number: 20110301209
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: November 24, 2008
    Publication date: December 8, 2011
    Applicant: TRAGARA PHARMACEUTICALS, INC.
    Inventors: Sara L. Zaknoen, Tracy Lawhon
  • Publication number: 20090017024
    Abstract: Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 15, 2009
    Applicant: Tragara Pharmaceuticals, Inc.
    Inventors: Thomas M. Estok, Sara L. Zaknoen, Robert K. Mansfield, Tracy Lawhon
  • Publication number: 20040223951
    Abstract: A method for treating a human patient afflicted with cancer, is provided in which therapeutically effective amounts of temozolomide and pegylated interferon alpha are administered to such a patient.
    Type: Application
    Filed: June 3, 2004
    Publication date: November 11, 2004
    Applicant: Schering Corporation
    Inventor: Sara L. Zaknoen
  • Publication number: 20040006087
    Abstract: Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.
    Type: Application
    Filed: December 3, 2002
    Publication date: January 8, 2004
    Applicant: Schering Corporation
    Inventors: David L. Cutler, Charles Baum, Sara L. Zaknoen
  • Publication number: 20030185831
    Abstract: Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.
    Type: Application
    Filed: November 25, 2002
    Publication date: October 2, 2003
    Applicant: Schering Corporation
    Inventors: David L. Cutler, Michael L. Meyers, Charles Baum, Sara L. Zaknoen
  • Publication number: 20020009428
    Abstract: A method for treating a human patient afflicted with cancer, is provided in which therapeutically effective amounts of temozolomide and pegylated interferon alpha are administered to such a patient.
    Type: Application
    Filed: January 22, 2001
    Publication date: January 24, 2002
    Inventor: Sara L. Zaknoen